Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02503813 · ClinicalTrials.gov registry record · NA
Does Venous pCO2 Increase by 20 mmHg or More During Apnea Challenge Test?
A NA study, sponsored by MemorialCare Health System.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT02503813 is a NA study that has completed, run by MemorialCare Health System. The registered enrollment target is 7 participants.
The verdict
NCT02503813, a NA study, has completed, sponsored by MemorialCare Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
One required examination for declaration of death by neurological criteria is the apnea challenge test. The apnea challenge test evaluates the medulla brainstem respiratory center response to a rise in CO2. The current guideline requires arterial sampling of CO2 and therefore either arterial puncture or arterial catheter placement for the examination. Arterial catheter is an invasive monitoring device and is not without complications. Recent studies have demonstrated that there is a direct correlation between peripheral venous and arterial blood gas measures and that peripheral venous CO2 measures may be used as alternatives to arterial CO2 measure.The purpose of this study is to evaluate brainstem response during the apnea challenge test to a rise in venous CO2 and correlate it with the rise in arterial measured CO2. The objective of this study is to demonstrate a similar rise between the venous and arterial CO2 during the apnea challenge test and eliminate the necessity of arterial blood sampling for the sole purpose of apnea challenge test in the future.
Interventions
- PROCEDURE venous blood gas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2015-07 |
| Est. Completion | 2017-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02503813
The ClinicalTrials.gov registry entry for NCT02503813 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MemorialCare Health System, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which venous blood gas is the first listed.
NCT02503813 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02503813 about?
NCT02503813 is a clinical study titled "Does Venous pCO2 Increase by 20 mmHg or More During Apnea Challenge Test?". One required examination for declaration of death by neurological criteria is the apnea challenge test. The apnea challenge test evaluates the medulla brainstem respiratory center response to a rise in CO2. The current guideline requires arterial sampling of CO2 and therefore either arterial punctur...
What is the current status of trial NCT02503813?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2015-07. Estimated completion is 2017-09.
What interventions are being tested in trial NCT02503813?
The interventions under investigation include: venous blood gas (PROCEDURE).
Who is sponsoring clinical trial NCT02503813?
This trial is sponsored by MemorialCare Health System, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.